Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Part of paid clinical trials in Mobile, Alabama.

Sponsor
Boston Scientific Corporation
Study ID
NCT06735534
Status
Recruiting

Conditions

  • Persistent Atrial Fibrillation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • FARAPULSE™ Pulsed Field Ablation System — DEVICE
    The FARAPULSE™ Pulsed Field Ablation System is indicated for the treatment of symptomatic atrial fibrillation. The FARAWAVE Catheter is indicated for the isolation of pulmonary veins and posterior wall in the treatment of drug-refractory, recurrent, symptomatic paroxysmal and persistent atrial fibrillation. The FARAWAVE Catheter is also indicated for the for the isolation of pulmonary veins and posterior wall in the treatment of persistent atrial fibrillation as an alternative to anti-arrhythmic drug (AAD) therapy as an initial rhythm control strategy. The FARAPOINT™ PFA Catheter is indicated for use as an adjunctive device for 1) the creation of an ablation line between the inferior vena cava and the tricuspid valve and/or 2) Mitral Isthmus, when the FARAWAVE Catheter is used in the endocardial treatment of persistent atrial fibrillation (episode duration no greater than 12 months).

Study Details

The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.

Key Dates

Start date
Jun 3, 2025
Status verified
May 2026
Primary completion
Apr 30, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
376 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Single Arm Prospective
    Repeat Ablation of Persistent Atrial Fibrillation, including Mitral Isthmus Catheter Ablation, with the FARAPULSE Pulsed Field Ablation System.

Primary Outcome Measure

Primary safety endpoint rate [ Time Frame: 60 days ]

Central Contacts

Locations (32)

FacilityCityStateZIPSite coordinators
Mobile Infirmary Medical CenterMobileAlabama36607
Rhonda Dickinson
E. Matthew Quin, MD (PRINCIPAL_INVESTIGATOR)
Arrhythmia Research Group-Research FacilityJonesboroArkansas72401
Tiffany Warhurst
870-275-8408
Devi Nair, MD (PRINCIPAL_INVESTIGATOR)
University of Southern California HospitalLos AngelesCalifornia90033
Silvia Perez
Ivan Ho, MD (PRINCIPAL_INVESTIGATOR)
St. John's Regional Medical CenterOxnardCalifornia93030
Daniel Aguda
Ali Sovari (PRINCIPAL_INVESTIGATOR)
Stanford University Medical CenterStanfordCalifornia94305
Alexander Perino, MD (PRINCIPAL_INVESTIGATOR)
South Denver Cardiology Associates, PCLittletonColorado80120
Rebecca Wimmer
Sri Sundaram, MD (PRINCIPAL_INVESTIGATOR)
HCA Florida Mercy HospitalMiamiFlorida33133
Isabel Vital
Jose Osorio, MD (PRINCIPAL_INVESTIGATOR)
Naples Comprehensive HealthNaplesFlorida34102
Dinesh Sharma, MD (PRINCIPAL_INVESTIGATOR)
AdventHealth Orlando-HospitalOrlandoFlorida32803
Omar Marquez
Naushad Shaik (PRINCIPAL_INVESTIGATOR)
AdventHealth Tampa-HospitalTampaFlorida33613
Daniel Robledo
Kenneth Yamamura (PRINCIPAL_INVESTIGATOR)
Tampa General HospitalTampaFlorida33606
David Wilson (PRINCIPAL_INVESTIGATOR)
Emory University HospitalAtlantaGeorgia30322
David Delurgio, MD (PRINCIPAL_INVESTIGATOR)
Memorial Health University Medical CenterSavannahGeorgia31404
Todd Senn, MD (PRINCIPAL_INVESTIGATOR)
St. Luke's Boise Medical CenterBoiseIdaho83712
Sharon LaMott
Marcos Daccarett, MD (PRINCIPAL_INVESTIGATOR)
Advocate Christ Medical Center-HospitalOak LawnIllinois60453
Ashley Boland
William Spear (PRINCIPAL_INVESTIGATOR)
Johns Hopkins HospitalBaltimoreMaryland21287
Michele Martucci
Jonathan Chrispin, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Moussa Mansour, MD (PRINCIPAL_INVESTIGATOR)
Southcoast Physicians GroupFall RiverMassachusetts02720
Debra Benevides
Ramin Davoudi, MD (PRINCIPAL_INVESTIGATOR)
William Beaumont Hospital-HospitalRoyal OakMichigan48073
Sarah Balasote
Nishaki Mehta (PRINCIPAL_INVESTIGATOR)
Dartmouth Hitchcock Medical CenterLebanonNew Hampshire03756
Brian Aldrich
Emily Zeitler, MD (PRINCIPAL_INVESTIGATOR)
Virtua Health Inc.MarltonNew Jersey08053
Kristin Broderick
Darius Sholevar, MD (PRINCIPAL_INVESTIGATOR)
Lovelace Medical CenterAlbuquerqueNew Mexico87102
Keisha Eggins
Yaw Adjei-Poku, MD (PRINCIPAL_INVESTIGATOR)
Northwell HealthManhassetNew York11030
Jonathan Willner (PRINCIPAL_INVESTIGATOR)
Weill Cornell Medical UniversityNew YorkNew York10065
Penn Collins
Jim Cheung (PRINCIPAL_INVESTIGATOR)
Bethesda North HospitalCincinnatiOhio45242
Laurie Freel
Marshall Winner, III, MD (PRINCIPAL_INVESTIGATOR)
Ohio State University Medical CenterColumbusOhio43210
Kalyn Ferguson
Salvatore Savona, MD (PRINCIPAL_INVESTIGATOR)
Oklahoma Heart InstituteTulsaOklahoma74104
Loyce Keeton
David Sandler (PRINCIPAL_INVESTIGATOR)
Trident Medical CenterCharlestonSouth Carolina29406
Molly Harper
Frank Cuoco, MD (PRINCIPAL_INVESTIGATOR)
Texas Cardiac Arrhythmia ResearchAustinTexas78705
Deb Cardinal
Andrea Natale, MD (PRINCIPAL_INVESTIGATOR)
Christus Trinity Mother Frances Health SystemTylerTexas75701
Adrian Maples
Stanislav Weiner, MD (PRINCIPAL_INVESTIGATOR)
St. Mark's HospitalSalt Lake CityUtah84124
Megan Miller
John Day, MD (PRINCIPAL_INVESTIGATOR)
Sentara Norfolk General HospitalNorfolkVirginia23507
Linette Klevan
Divyang Patel, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Mobile, AL

Related Studies